Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5 results about "Immunoglobulin genes" patented technology

The multigene organization of immunoglobulin genes. From studies and predictions such as Dreyer and Bennett's, it shows that the light chains and heavy chains are encoded by separate multigene families on different chromosomes. They are referred to as gene segments and are separated by non-coding regions.

Application of ginseng extract in preparation of feed additive for resisting infection of aeromonas hydrophila

ActiveCN120036423BAntibacterial agentsAnimal feeding stuffGINSENG EXTRACTImmunoglobulin levels
The application discloses application of Gastrodia elata extract in preparation of a feed additive for resisting Aeromonas hydrophila infection, and belongs to the technical field of water animal disease prevention and treatment. The application first finds that the Gastrodia elata extract has a significant effect of inhibiting Aeromonas hydrophila infection. After the Gastrodia elata extract is added into water animal feed as a feed additive and is fed to the water animal, the Gastrodia elata extract is absorbed into blood circulation system through a digestive tract, up-regulates intestinal immunoglobulin gene expression, improves serum immunoglobulin level, enhances intestinal barrier function, improves animal activity, effectively resists Aeromonas hydrophila infection, reduces disease occurrence, and improves yield and quality of animal breeding. Therefore, the Gastrodia elata extract has a good application prospect.
Owner:HUAZHONG AGRI UNIV +1

Humanized antibody mouse

PendingCN122104812AMicroinjection basedStable introduction of DNAHeavy chainHumanized antibody
The present application relates to a genetically modified non-human animal comprising a humanized heavy chain immunoglobulin locus and / or a humanized light chain immunoglobulin locus and methods of making the same. The present application also provides methods of producing antibodies by the non-human animal.
Owner:SHANGHAI BIOMODEL ORGANISM SCI & TECH DEV

Genetically modified non-human animals with humanized immunoglobulin locus

PendingHK40135111AGlobulinVirology
The present disclosure relates to genetically modified animals and cells having a humanized lambda light chain immunoglobulin locus and / or a humanized heavy chain immunoglobulin locus. The disclosure also relates to genetically modified animals and cells having a modified locus comprising a human lambda light chain immunoglobulin gene and / or a humanized heavy chain immunoglobulin locus. In some embodiments, the animal also has a humanized kappa light chain immunoglobulin locus.
Owner:BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO LTD

Non-human animals possessing engineered immunoglobulin λ light chains and the uses of said non-human animals.

ActiveCN116058333BImmunoglobulinsEnzymesImmunoglobulin light chainHuman cell
Non-human animals (and / or non-human cells) and methods for using said non-human animals (and / or non-human cells) are provided, said non-human animals (and / or non-human cells) having a genome containing sequences encoding human antibodies (i.e., immunoglobulin genes). The non-human animals described herein express antibodies containing immunoglobulin (Ig) light chains, said immunoglobulin light chains being characterized by the presence of a human Vλ domain. In some embodiments, the non-human animals provided herein are characterized by expressing antibodies containing a human Vλ light chain encoded by a sequence encoding a human Igλ light chain inserted into an endogenous Igκ light chain locus of said non-human animal. Methods for producing antibodies from non-human animals are also provided, said antibodies containing a human variable region and a mouse constant region.
Owner:REGENERON PHARMACEUTICALS INC